Serum Sestrin-1 Concentration Is Higher in Frail than Non-Frail Older People Living in Nursing Homes
- PMID: 35162104
- PMCID: PMC8834059
- DOI: 10.3390/ijerph19031079
Serum Sestrin-1 Concentration Is Higher in Frail than Non-Frail Older People Living in Nursing Homes
Abstract
Given the increasing prevalence of frailty and its implications for public health, the identification of biomarkers to detect frailty is essential. Sestrin-1 is a protein with a protective role in muscle function. This study aimed to determine whether the serum sestrin-1 concentration differed between frail and non-frail populations and to investigate its association with frailty-related variables in 225 older women and men living in nursing homes (Gipuzkoa, Spain). Serum sestrin-1 concentration was measured by ELISA. Frailty, dependence, anthropometry, physical function, and physical activity were determined by validated tests and tools. The associations between sestrin-1 concentration and the other variables were determined using generalized linear models. The differences between frail and non-frail individuals were analyzed by the Mann-Whitney U-test, and receiver operating characteristic (ROC) curves were constructed to calculate the capability of sestrin-1 to detect frailty. Unexpectedly, frail individuals-according to the Fried Frailty Phenotype or the Clinical Frailty Scale-had higher serum sestrin-1 concentrations than non-frail individuals. Furthermore, the higher serum sestrin-1 concentration was associated with the increased frailty scores and dependence as well as the poorer physical function and the less physical activity. Given the contradictory results regarding serum sestrin-1 and frailty, further investigation is required to propose it as a molecular biomarker of frailty.
Keywords: aging; biomarker; dependence; frailty; physical activity; physical function; sestrin-1.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; nor in the collection, analyses, or interpretation of data; nor in the writing of the manuscript or the decision to publish the results.
Figures
References
-
- Fried L.P., Tangen C.M., Walston J., Newman A.B., Hirsch C., Gottdiener J., Seeman T., Tracy R., Kop W.J., Burke G., et al. Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: Evidence for a phenotype. J. Gerontol. Biol. Sci. Med. Sci. 2001;56:M146–M156. doi: 10.1093/gerona/56.3.M146. - DOI - PubMed
-
- Dent E., Morley J.E., Cruz-Jentoft A.J., Woodhouse L., Rodríguez-Mañas L., Fried L.P., Woo J., Aprahamian I., Sanford A., Lundy J., et al. Physical frailty: ICFSR international clinical practice guidelines for identification and management. J. Nutr. Health Aging. 2019;23:771–787. doi: 10.1007/s12603-019-1273-z. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
